|
| NZWJKTHFNLHUJO-NWZSJJIMSA-N Basic information |
Product Name: | NZWJKTHFNLHUJO-NWZSJJIMSA-N | Synonyms: | NZWJKTHFNLHUJO-NWZSJJIMSA-N;Rosuvastatin 2,3-Anhydro Acid Calcium Salt;((S,2Z,6E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethyl sulfonamido)pyrimidin-5-yl)-5-hydroxyhepta-2,6-dienoate) calcium(II);Rosuvastatin calcium-10;2,6-Heptadienoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-, (2Z,5S,6E)-;2Z,Dehydro Rosuvastatin;2,3-Anhydro Rosuvastatin Calcium Salt/ Rosuvastatin 2,6-Diene Impurity;Rosuvastatin EP Impurity K (2Z-isomer) | CAS: | 1422954-12-8 | MF: | C22H26FN3O5S | MW: | 463.52 | EINECS: | | Product Categories: | | Mol File: | 1422954-12-8.mol | |
| NZWJKTHFNLHUJO-NWZSJJIMSA-N Chemical Properties |
Boiling point | 717.9±70.0 °C(Predicted) | density | 1.333±0.06 g/cm3(Predicted) | solubility | DMSO (Slightly), Methanol (Slightly) | form | Solid | pka | 4.30±0.25(Predicted) | color | White to Off-White | Stability: | Hygroscopic, Light Sensitive |
| NZWJKTHFNLHUJO-NWZSJJIMSA-N Usage And Synthesis |
Uses | Dehydro Rosuvastatin is an impurity of Rosuvastatin (R700500) which is a selective, competitive HMG-CoA reductase inhibitor. Antilipemic. |
| NZWJKTHFNLHUJO-NWZSJJIMSA-N Preparation Products And Raw materials |
|